There seems to be a consensus amongst medical professionals and researchers that patients don’t want to test their glucose regardless of how bad their condition is. It appears that CGMS is the future according to a lot of experts. But is it feasible in the real world? This week, we …

In part 7, the conclusion of this Exclusive Interview, Dr. Ray Kausik talks with Diabetes in Control Publisher Steve Freed during the ADA 2017 convention in San Diego, CA about the side effects so far of the new inhibitor drug and watching for reactions.

In this week's Homerun Slides, the impact of diabetes medication on the heart and other organs, and the frequency of hypoglycemia.

OSA epidemiology and risk factors: The prevalence of OSA varies considerably between studies, mainly due to differences in the population studied, study designs, and the method and criteria used to diagnose OSA. A prevalence of 4% in men and 2% in women has traditionally been quoted in many populations. The prevalence from three well-conducted studies with similar design from Wisconsin, Pennsylvania, and Spain showed an OSA prevalence of 17–26% in men and 9–28% in women and a prevalence of 9–14% and 2–7% for men and women with moderate to severe OSA. These studies used a two-stage sampling design which allows some degree of estimate of the “self-selection” bias which is usually a significant problem in OSA studies.